Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

The mouse models are effective for testing new hair loss treatments.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.